US Patent 7977330 Salts and crystal modifications thereof
Patent 7977330 was granted and assigned to Novartis on July, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+270 characters)
Article
Patent abstract
The invention relates to salts of 1-(2-Fluoro-phenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea and crystalline forms thereof, their production and usage, and pharmaceutical preparations containing such salts and crystalline forms.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07977330 Salts and crystal modifications thereof US Patent 7977330 Salts and crystal modifications thereof
Infobox
Patent Number
0797733000
Patent Number
797733000
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079773300
Date of Patent
July 12, 2011
0Patent Application Number
122982030
Date Filed
May 21, 2007
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079773300
Date of Patent
July 12, 2011
0Patent Application Number
122982030
Date Filed
May 21, 2007
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07977330 Salts and crystal modifications thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07977330
Date of patent
July 12, 2011
Patent application number
12298203
Date Filed
May 21, 2007
Patent primary examiner
Find more entities like US Patent 7977330 Salts and crystal modifications thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
